Evidence map›Paper›PMID 36951251›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2023

Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred.

Jesse Nicholas Cochran, Juliana Acosta-Uribe, Bianca T Esposito, Lucia Madrigal, David Aguillón, Margarita M Giraldo, Jared W Taylor, Joseph Bradley, Brian Fulton-Howard, Shea J Andrews and 20 more

Open access · greenAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Promoter mutagenesis and a massively parallel reporter screen of thebioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. The New England journal of medicine · 2024
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 7 institutions in 2 countries.

Jesse Nicholas CochranHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.ORCID 0000-0002-9852-5504
Juliana Acosta-UribeNeuroscience Research Institute, University of California, Santa Barbara, California, and Department of Molecular Cellular and Developmental Biology University of California, Santa Barbara, California, USA.
Bianca T EspositoDepartment of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lucia MadrigalGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
David AguillónGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Margarita M GiraldoGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Jared W TaylorHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Joseph BradleyWashington University School of Medicine, St. Louis, Missouri, USA.
Brian Fulton-HowardDepartment of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Shea J AndrewsDepartment of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Natalia Acosta-BaenaGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Diana AlzateGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Gloria P GarciaGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Francisco PiedrahitaGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Hugo E LopezGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Ashlyn G AndersonHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Ivan Rodriguez-NunezHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Kevin RobertsHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Dominantly Inherited Alzheimer NetworkWashington University School of Medicine, St. Louis, Missouri, USA.
Devin AbsherHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Richard M MyersHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Gary W BeechamThe John P. Hussman Institute for Human Genomics, University of Miami, Miami, Florida, USA.
Christiane ReitzDepartment of Epidemiology, Sergievsky Center, Taub Institute for Research on the Aging Brain, Columbia University, New York, New York, USA.
Lindsay F RizzardiHudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
Maria Victoria FernandezWashington University School of Medicine, St. Louis, Missouri, USA.
Alison M GoateDepartment of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Carlos CruchagaWashington University School of Medicine, St. Louis, Missouri, USA.
Alan E RentonDepartment of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Francisco LoperaGrupo de Neurociencias de Antioquia. School of Medicine. Universidad de Antioquia, Medellín, Antioquia, Colombia.
Kenneth S KosikNeuroscience Research Institute, University of California, Santa Barbara, California, and Department of Molecular Cellular and Developmental Biology University of California, Santa Barbara, California, USA.
Universidad de Antioquia · COHudsonAlpha Institute for Biotechnology · USIcahn School of Medicine at Mount Sinai · USWashington University in St. Louis · USUniversity of California, Santa Barbara · USInstitute on Aging · USUniversity of Miami · US

Funding

Project 4 (Genetic modifiers for APOE-associated Alzheimer's disease pathogenesis)U19AG069701 · NIA · MAYO CLINIC JACKSONVILLE · PI Celeste Marie Karch · 2021 to 2026
$42.0M
Project 3: Autophagy dysfunction and neuronal activity in FTDU54NS100717 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI GAN, LI · 2016 to 2020
$10.8M
The complex interaction between Alzheimer drivers and agingRF1AG062479 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KOSIK, KENNETH STEPHEN · 2020 to 2020
$2.6M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Elucidating the causal associations underlying Alzheimer's diseaseR00AG070109 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDREWS, SHEA J · 2023 to 2025
$742k
The complex interaction between Alzheimer drivers and agingR56AG062479 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KOSIK, KENNETH STEPHEN · 2019 to 2019
$732k
Regulatory mechanisms of rare non-coding variation in neurodegeneration-associated lociR00AG068271 · NIA · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI COCHRAN, JESSE N · 2021 to 2023
$725k
NIA NIH HHS R00 AG068271NIA NIH HHS R00 AG070109NIA NIH HHS R56 AG062479NIA NIH HHS U19 AG069701NIH HHS S10 OD026880NIH HHS S10 OD030463NINDS NIH HHS U54 NS100717
6 · The paper itself

Abstract

introductionGenetic associations with Alzheimer's disease (AD) age at onset (AAO) could reveal genetic variants with therapeutic applications. We present a large Colombian kindred with autosomal dominant AD (ADAD) as a unique opportunity to discover AAO genetic associations.

methodsA genetic association study was conducted to examine ADAD AAO in 340 individuals with the PSEN1 E280A mutation via TOPMed array imputation. Replication was assessed in two ADAD cohorts, one sporadic early-onset AD study and four late-onset AD studies.

results13 variants had p<1×10 DISCUSSION: Variants with suggestive associations with AAO were associated with biological processes including clusterin, heparin sulfate, and amyloid processing. The detection of these effects in the presence of a strong mutation for ADAD reinforces their potentially impactful role.

Indexed as

Alzheimer DiseaseClusterinAge of OnsetAmyloidColombiaHumansMutationPresenilin-1AmyloidClusterinPresenilin-1PSEN1 protein, humanAAOACEage of onsetAlzheimeramyloidAOOCLUclusterinE280Aheparin sulfateHS3ST1HSPG2LRP1BPSEN1SIAH3tetraspaninTSPAN10TSPAN14ZC3H13

Identifiers

PMID36951251
PMCPMC10514237
OpenAlexW4360601157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.